The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000138.5(FBN1):c.79G>A (p.Ala27Thr)

CA017499

163486 (ClinVar)

Gene: FBN1
Condition: Marfan syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 06981afe-9f52-4bdc-b6e0-b30bad5cda4d
Approved on: 2023-09-28
Published on: 2023-09-28

HGVS expressions

NM_000138.5:c.79G>A
NM_000138.5(FBN1):c.79G>A (p.Ala27Thr)
NC_000015.10:g.48644691C>T
CM000677.2:g.48644691C>T
NC_000015.9:g.48936888C>T
CM000677.1:g.48936888C>T
NC_000015.8:g.46724180C>T
NG_008805.2:g.6098G>A
ENST00000316623.10:c.79G>A
ENST00000316623.9:c.79G>A
ENST00000537463.6:c.79G>A
ENST00000558230.1:n.142G>A
ENST00000560355.1:c.79G>A
NM_000138.4:c.79G>A

Benign

Met criteria codes 2
BA1 BP4
Not Met criteria codes 1
BP2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
FBN1 VCEP
The NM_000138.5 c.79G>A, is a missense variant in FBN1 predicted to cause a substitution of a alanine acid by threonine at amino acid 27 (p.Ala27Thr). This variant has been previously reported in ClinVar as likely benign and benign (Variation ID: 163486). This variant has been identified in 129/19954 (0.65%) of individuals of East Asian origin (MAF: 0.65%) (BA1; https://gnomad.broadinstitute.org/ version 2.1.1). It has been reported in individuals with thoracic aortic aneurysm and/or dissection, and in individuals with clinical features of Marfan syndrome, however it was considered to be a polymorphism (PMID 26272055, 19839986, 16835936). Computational prediction tools and conservation analysis suggests no impact on the protein (REVEL: 0.097) (BP4). The constraint z-score for missense variants affecting FBN1 is 5.06, however due to the presence of two benign arguments, PP2 cannot be used. In summary, this variant meets criteria to be classified as benign for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGenFBN1 VCEP: BA1, BP4.
Met criteria codes
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Not Met criteria codes
BP2
Identified in a proband who also carried a pathogenic variant in FBN1
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.